These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 393546)

  • 21. [Therapeutic studies of Clostridium butyricum spores, cyclophosphamide and prednisolone in amelanotic melanoma in Syrian gold hamsters].
    Kretschmer H; Ludewig R; Hambsch K; Wohlrab W; Peker J
    Dermatol Monatsschr; 1973 Dec; 159(12):1089-94. PubMed ID: 4802043
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination therapy: some concepts and results.
    Skipper HE
    Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
    [No Abstract]   [Full Text] [Related]  

  • 23. [Changes in the metastasis of experimental tumors and in the antimetastatic effect of cytostatics in their pharmacological action on adrenergic processes].
    Veksler IG; Riabukha VN; Smelkova MI; Balitskiĭ KP
    Eksp Onkol; 1984; 6(6):50-3. PubMed ID: 6441701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro methods to complement in vivo approaches utilizing combinations of chemotherapy and immunotherapy.
    Sigel MM; Lichter W; Lopez DM
    Cancer Chemother Rep 2; 1974 Mar; 4(1):109-14. PubMed ID: 4133186
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.
    Bajetta E; Rovej R; Buzzoni R; Vaglini M; Bonadonna G
    Cancer Treat Rep; 1982 Jun; 66(6):1299-302. PubMed ID: 6177408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Green SJ
    Cancer Treat Rep; 1982 Mar; 66(3):567-9. PubMed ID: 6174231
    [No Abstract]   [Full Text] [Related]  

  • 28. New trends in the treatment of malignant melanoma.
    Veronesi U; Bajetta E; Cascinelli N; Clemente C; Rilke F
    Int Adv Surg Oncol; 1978; 1():113-56. PubMed ID: 399762
    [No Abstract]   [Full Text] [Related]  

  • 29. [Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].
    Pathol Biol (Paris); 1990 Oct; 38(8):876-80. PubMed ID: 2274396
    [No Abstract]   [Full Text] [Related]  

  • 30. [Medical therapy of tumors. II].
    Cerimele E
    Clin Ter; 1979 Nov; 91(3):279-314. PubMed ID: 397032
    [No Abstract]   [Full Text] [Related]  

  • 31. [DTIC in the therapy of solid tumours (author's transl)].
    Kokron O; Pridun N; Zischinsky W
    Wien Klin Wochenschr; 1978 Dec; 90(24):864-7. PubMed ID: 741753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemotherapy of malignant melanoma].
    Wagenknecht L
    Schweiz Med Wochenschr; 1973 Oct; 103(41):1426-8. PubMed ID: 4127413
    [No Abstract]   [Full Text] [Related]  

  • 33. Procarbazine, vincristine, CCNU, and cyclophosphamide (POCC) in the treatment of metastatic malignant melanoma.
    Green MR; Dillman RO; Horton C
    Cancer Treat Rep; 1980 Jan; 64(1):139-42. PubMed ID: 7379047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
    Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
    Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapy of melanoma].
    Bernheim JL; Kenis Y
    Acta Chir Belg; 1974 Mar; 73(2):249-63. PubMed ID: 4450922
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of malignant melanoma.
    Rosin RD
    Eur J Surg Oncol; 1985 Jun; 11(2):111-5. PubMed ID: 3891412
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunotherapy: Anti-PD-1 therapies-a new first-line option in advanced melanoma.
    Sullivan RJ; Flaherty KT
    Nat Rev Clin Oncol; 2015 Nov; 12(11):625-6. PubMed ID: 26416151
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.
    Berman E; Casper ES; Howard J; Wittes RE
    Cancer Treat Rep; 1984 Apr; 68(4):679-80. PubMed ID: 6585272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Past and current problems in tumor research].
    von Wasielewski E; Sedlacek HH
    Dtsch Med Wochenschr; 1986 Apr; 111(16):630-7. PubMed ID: 3956405
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of the immunological reactivity of melanoma patients using the rosette formation test].
    Trapeznikov NN; Kupin VI; Radzikhovskaia RM; Kadagidze ZG
    Dokl Akad Nauk SSSR; 1975 May; 222(2):468-71. PubMed ID: 1132298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.